Grupo de investigación cardiovascular
GRINCAR
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (7)
2022
-
Persistence and Waning of Natural SARS-CoV-2 Antibodies Over 18 Months: Long-Term Durability of IgG Humoral Response in Healthcare Workers
Journal of General Internal Medicine
-
Serum potassium dynamics during acute heart failure hospitalization
Clinical Research in Cardiology, Vol. 111, Núm. 4, pp. 368-379
-
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation
JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560
2021
-
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
Frontiers in Cardiovascular Medicine, Vol. 8
2020
-
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study
JACC: Heart Failure, Vol. 8, Núm. 10, pp. 822-833
2019
-
POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas
Journal of the American Heart Association, Vol. 8, Núm. 18, pp. e012875
2016
-
Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology
European Journal of Heart Failure, Vol. 18, Núm. 3, pp. 226-241